Patents by Inventor Limor Cohen

Limor Cohen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • BLOOD-BASED PROTEIN BIOMARKER PANEL FOR EARLY AND ACCURATE DETECTION OF CANCER
    Publication number: 20240036045
    Abstract: Methods and compositions for accurate blood biomarker panel-based detection of cancer, e.g., breast cancer, and sub-typing, e.g., using ultrasensitive immunoassays, e.g., digital ELISA.
    Type: Application
    Filed: December 22, 2021
    Publication date: February 1, 2024
    Inventors: Limor Cohen, David R. Walt, Evan Laurence Busch
  • BIOMARKER PANELS FOR ON-TREATMENT PREDICTION OF RESPONSE TO IMMUNO-ONCOLOGY DRUGS
    Publication number: 20220011313
    Abstract: Biomarker panels for the prediction of patient response to immunotherapy, and methods of use thereof.
    Type: Application
    Filed: December 16, 2019
    Publication date: January 13, 2022
    Inventors: Alissa Keegan, David R. Walt, Limor Cohen
  • DROPLET ARRAYS FOR DETECTION AND QUANTIFICATION OF ANALYTES
    Publication number: 20210164971
    Abstract: The invention provides high-sensitivity methods for detection and quantification of target analytes in liquid samples (e.g., biological or environmental samples). The methods can be multiplexed to allow simultaneous detection and quantification of multiple target analytes that are contained in the same sample. The invention also provides related compositions and kits.
    Type: Application
    Filed: August 15, 2019
    Publication date: June 3, 2021
    Inventors: David R. Walt, Limor Cohen, David A. Weitz, Nai Wen Cui, Yamei Cai
  • ULTRASENSITIVE ASSAYS FOR DETECTION OF SHORT NUCLEIC ACIDS
    Publication number: 20200032326
    Abstract: Described herein are ultrasensitive methods to detect the presence and/or measure the levels of short target nucleic acids, such as microRNAs, in a sample. Such a method can involve the use of a capture probe and a detection probe, each of which is complementary to a segment of the short target nucleic acid. The capture probe and a detection probe may be hybridized with the target nucleic acid in the sample and the complex thus formed can be detected, for example, by a single molecular array assay.
    Type: Application
    Filed: May 29, 2019
    Publication date: January 30, 2020
    Applicant: Trustees of Tufts College
    Inventors: David R. Walt, Limor Cohen, Mark Hartman